Partner Content Partner Content 6 Ways To Finally Drug RAS Oncogenes Are You Developing Effective Anti-RAS Therapeutics?
Partner Content Partner Content Boehringer Ingelheim to present data at RAS Summit Europe RAS- Targeted Drug Discovery Europe Conference
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.